Popular Articles

As The Market Potential Grows, Developers Press For Keys To Delivering Systemic Drugs Via Inhalation
At a time when the drug industry is striving for patient-friendly delivery methods for new and existing drugs, the growing availability of innovative inhaler device designs is driving interest in pulmonary drug delivery technology and devices as an alternative to oral and parenteral routes of administration. While well-established for treating upper respiratory diseases such as asthma and COPD, companies competing in the inhaled drug delivery sector - major players such as GlaxoSmithKline, AstraZeneca and Boehringer Ingelheim as well as pure-play start-ups - continue to view delivery of systemic drugs via inhalation as a major opportunity.
diet pills
Unique Collaboration Between TB Alliance And Tibotec To Accelerate Tuberculosis Drug Development
A new landmark collaboration between the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership, and Tibotec Inc., (Tibotec), a global pharmaceutical company, has been announced at the Pacific Health Summit in response to the urgent need to accelerate the discovery and development of new drugs to fight tuberculosis (TB).
News of the day
Mini-stroke Patients Get Better Care In Hospitals With Stroke Services
Patients who suffer from transient ischaemic attack (so-called "mini-strokes") are more likely to receive rapid assessment and care if they attend a hospital which has organised stroke care services, according to the results of a survey published in the Medical Journal of Australia.
Oncology

MCG Dental Student Places First In National Research Competition

He"s already shown that a blue curing light stunts tumor growth. Now the senior in the Medical College of Georgia School of Dentistry is trying to identify the proteins responsible. Alpesh Patel recently placed first in the American Association for Dental Research National Student Research Group DENTSPLY/Caulk Basic Science Research Competition. Only seven students nationwide are selected to participate annually. He found that blue curing light, used to harden dental fillings, activates signaling pathways that can cause cancer cells to die. Alpesh, who has primarily been working with Dr. Jill Lewis, associate professor of oral biology in the School of Dentistry, found that oral cancer cell growth was reduced in mice treated with blue curing light compared to untreated mice. Now, he"s studying which proteins cause this response in hopes of improving treatment for oral cancer. Today"s treatment generally includes surgery, radiation and chemotherapies. "Oral cancer survivors often suffer significant morbidity due to impaired speech, swallowing, taste or facial disfigurement following treatment," Alpesh says. "No substantial advances have been made in oral cancer treatment for years, but using a blue curing light to shrink or destroy oral cancer cells could be a very effective and less-invasive treatment alternative." After graduation, Alpesh plans to specialize in orthodontics and is eager to continue researching during his residency. "After I had braces, I saw how much of an effect they had on my self-esteem, and I would love to help others not only fix their smiles but also improve their confidence," says Alpesh. "And I"ve also always been interested in research and how it can help patients." Amy Connell Medical College of Georgia


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):